Seroatlas · Human Serome Atlas

CHCHD2

Coiled-coil-helix-coiled-coil-helix domain-containing protein 2

Also known as: C7orf17, CHCH2_HUMAN, MIX17B, MNRR1

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9Y6H1
Gene
CHCHD2
Ensembl
ENSG00000106153
Chromosome
7
Canonical length
151 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins
Subcellular location
Mitochondria

OverviewNCBI Gene

The protein encoded by this gene belongs to a class of eukaryotic CX(9)C proteins characterized by four cysteine residues spaced ten amino acids apart from one another. These residues form disulfide linkages that define a CHCH fold. In response to stress, the protein translocates from the mitochondrial intermembrane space to the nucleus where it binds to a highly conserved 13 nucleotide oxygen responsive element in the promoter of cytochrome oxidase 4I2, a subunit of the terminal enzyme of the electron transport chain. In concert with recombination signal sequence-binding protein J, binding of this protein activates the oxygen responsive element at four percent oxygen. In addition, it has been shown that this protein is a negative regulator of mitochondria-mediated apoptosis. In response to apoptotic stimuli, mitochondrial levels of this protein decrease, allowing BCL2-associated X protein to oligomerize and activate the caspase cascade. Pseudogenes of this gene are found on multiple chromosomes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

Canonical amino-acid sequenceUniProt

151 residues, UniProt reviewed canonical sequence.

>Q9Y6H1|CHCHD2
     1  MPRGSRSRTS RMAPPASRAP QMRAAPRPAP VAQPPAAAPP SAVGSSAAAP RQPGLMAQMA
    61  TTAAGVAVGS AVGHTLGHAI TGGFSGGSNA EPARPDITYQ EPQGTQPAQQ QQPCLYEIKQ
   121  FLECAQNQGD IKLCEGFNEV LKQCRLANGL A

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CHCHD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.66
Highest tissue expression
854 nTPM

Expression across tissuesHPA

Tissue

  • skeletal muscle: 854 nTPM
  • adrenal gland: 738 nTPM
  • tongue: 552 nTPM
  • choroid plexus: 509 nTPM
  • heart muscle: 449 nTPM
  • midbrain: 440 nTPM

Single-cell type

  • gastric progenitor cells: 1,942 nCPM
  • esophageal suprabasal cells: 1,815 nCPM
  • esophageal apical cells: 1,808 nCPM
  • esophageal basal cells: 1,483 nCPM
  • extravillous trophoblasts: 1,473 nCPM
  • epididymal principal cells: 1,422 nCPM

Immune cell

  • total PBMC: 1,067 nTPM
  • plasmacytoid DC: 787 nTPM
  • myeloid DC: 577 nTPM
  • T-reg: 553 nTPM
  • classical monocyte: 510 nTPM
  • non-classical monocyte: 470 nTPM

Brain region

  • white matter: 325 nTPM
  • cerebellum: 311 nTPM
  • thalamus: 298 nTPM
  • spinal cord: 296 nTPM
  • hypothalamus: 294 nTPM
  • choroid plexus: 289 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CHCHD2.

Disease | AllUniProt

Conditions CHCHD2 is implicated in, by any mechanism.

Disease | GeneticClinVar

2 pathogenic / likely-pathogenic of 113 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.9
gnomAD pLI
0
gnomAD missense Z
0.12
DepMap mean gene effect
-0.37
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CHCHD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CHCHD2 as an antibody target. Whether an autoantibody or antibody against CHCHD2 could matter depends on whether native CHCHD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CHCHD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CHCHD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CHCHD2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...